Maria-Elisabeth Goebeler

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

Maria-Elisabeth Goebeler, Stefan Knop, Andreas Viardot et al. · Journal of Clinical Oncology · 2016 · 421 citations

Medicine, Hematology, Oncology +17

Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma

Matteo Da Vià, Oliver Dietrich, Marietta Truger et al. · Nature Medicine · 2021 · 328 citations

Life Sciences, Immunology, Oncology +15

Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML

Martin Wermke, Sabrina Kraus, Armin Ehninger et al. · Blood · 2021 · 164 citations · Full text

Life Sciences, Translational Sciences, Immunotherapy +5

Pasotuxizumab, a Bite ^® Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings

Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich et al. · Immunotherapy · 2020 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

Poor efficacy and tolerability of <scp>R‐CHOP</scp> in relapsed/refractory chronic lymphocytic leukemia and <scp>R</scp>ichter transformation

Petra Langerbeins, Raymonde Busch, Nadine Anheier et al. · American Journal of Hematology · 2014 · 112 citations · Full text

Medicine, Hematology, Oncology +17